Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Bringer, J; Raingeard, I; Lefebvre, P; Renard, E
   Suitable forms of contraception for diabetic women
   DIABETES & METABOLISM
   
   J. Bringer et al., "Suitable forms of contraception for diabetic women", DIABETE MET, 27(4), 2001, pp. S35-S41
2. Renard, E; Raingeard, I; Boulot, P; Bringer, J
   Management of insulin treatment in type 1 diabetes mellitus in prospect for and during pregnancy: Means and objectives.
   DIABETES & METABOLISM
   
   E. Renard et al., "Management of insulin treatment in type 1 diabetes mellitus in prospect for and during pregnancy: Means and objectives.", DIABETE MET, 27(4), 2001, pp. S61-S66
3. Perez-Martin, A; Dumortier, M; Raynaud, E; Brun, JF; Fedou, C; Bringer, J; Mercier, J
   Balance of substrate oxidation during submaximal exercise in lean and obese people
   DIABETES & METABOLISM
   
   A. Perez-Martin et al., "Balance of substrate oxidation during submaximal exercise in lean and obese people", DIABETE MET, 27(4), 2001, pp. 466-474
4. Bringer, J; Raingeard, I; Renard, E; Grigorescu, F; Lefebvre, P
   Insulin sensitivity and polycystic ovarian syndrome
   DIABETES & METABOLISM
   
   J. Bringer et al., "Insulin sensitivity and polycystic ovarian syndrome", DIABETE MET, 27(2), 2001, pp. 239-245
5. Renard, E; Rostane, T; Carriere, C; Marchandin, H; Jacques-Apostol, D; Lauton, D; Gibert-Boulet, F; Bringer, J
   Implantable insulin pumps: Infections most likely due to seeding from skinflora determine severe outcomes of pump-pocket seromas
   DIABETES & METABOLISM
   
   E. Renard et al., "Implantable insulin pumps: Infections most likely due to seeding from skinflora determine severe outcomes of pump-pocket seromas", DIABETE MET, 27(1), 2001, pp. 62-65
6. El Mkadem, SA; Lautier, C; Macari, F; Molinari, N; Lefebvre, P; Renard, E; Gris, JC; Cros, G; Daures, JP; Bringer, J; White, MF; Grigorescu, F
   Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome
   DIABETES
   
   S.A. El Mkadem et al., "Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome", DIABETES, 50(9), 2001, pp. 2164-2168
7. Pujol, P; Daures, JP; Brouillet, JP; Chang, S; Rouanet, P; Bringer, J; Grenier, J; Maudelonde, T
   A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma
   CANCER
   
   P. Pujol et al., "A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma", CANCER, 91(10), 2001, pp. 1854-1861
8. Pujol, P; De Boisvilliers, F; Bringer, J; Jaffiol, C
   Effects of thyrotropin suppression with tri-iodothyroacetic acid on radionuclide cardiovascular parameters
   THYROID
   
   P. Pujol et al., "Effects of thyrotropin suppression with tri-iodothyroacetic acid on radionuclide cardiovascular parameters", THYROID, 10(11), 2000, pp. 1017-1018
9. Chanson, P; Boerlin, V; Ajzenberg, C; Bachelot, Y; Benito, P; Bringer, J; Caron, P; Charbonnel, B; Cortet, C; Delemer, B; Escobar-Jimenez, F; Foubert, L; Gaztambide, S; Jockenhoevel, F; Kuhn, JM; Leclere, J; Lorcy, Y; Perlemuter, L; Prestele, H; Roger, P; Rohmer, V; Santen, R; Sassolas, G; Scherbaum, WA; Schopohl, J; Torres, E; Varela, C; Villamil, F; Webb, SM
   Comparison of octreotide acetate LAR and lanreotide SR in patients with acromegaly
   CLINICAL ENDOCRINOLOGY
   
   P. Chanson et al., "Comparison of octreotide acetate LAR and lanreotide SR in patients with acromegaly", CLIN ENDOCR, 53(5), 2000, pp. 577-586
10. Rouayrenc, JF; Vignon, F; Bringer, J; Pujol, P
    Non-genomic steroid effects: estrogen action revisited
    ANNALES D ENDOCRINOLOGIE
    
    J.F. Rouayrenc et al., "Non-genomic steroid effects: estrogen action revisited", ANN ENDOCR, 61(6), 2000, pp. 517-523
11. Galtier-Dereure, F; Boegner, C; Bringer, J
    Obesity and pregnancy: complications and cost
    AMERICAN JOURNAL OF CLINICAL NUTRITION
    
    F. Galtier-Dereure et al., "Obesity and pregnancy: complications and cost", AM J CLIN N, 71(5), 2000, pp. 1242S-1248S
12. Jaffiol, C; Baccara, MT; Renard, E; Apostol, DJ; Lefebvre, P; Boulot, P; Daures, JP; Bringer, J
    Incidence of the preconceptional management of type 1 diabetes on the outcome of pregnancy
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE
    
    C. Jaffiol et al., "Incidence of the preconceptional management of type 1 diabetes on the outcome of pregnancy", B ACA N MED, 184(5), 2000, pp. 995-1008
13. Peyreigne, C; Fedou, C; Benhaddad, AA; de Boisvilliers, F; Mercier, J; Bringer, J; Brun, JF
    Hemorheology of growth hormone-deficient adults
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    
    C. Peyreigne et al., "Hemorheology of growth hormone-deficient adults", CL HEMORH M, 20(3), 1999, pp. 167-174
14. Benhaddad, AA; Bouix, D; Khaled, S; Micallef, JP; Mercier, J; Bringer, J; Brun, JF
    Early hemorheologic aspects of overtraining in elite athletes
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    
    A.A. Benhaddad et al., "Early hemorheologic aspects of overtraining in elite athletes", CL HEMORH M, 20(2), 1999, pp. 117-125
15. Thivolet, C; Vialettes, B; Boitard, C; Bringer, J
    No evidence that anti hepatitis B vaccine causes insulin dependent diabetes mellitus.
    DIABETES & METABOLISM
    
    C. Thivolet et al., "No evidence that anti hepatitis B vaccine causes insulin dependent diabetes mellitus.", DIABETE MET, 25(5), 1999, pp. 441-445
16. Sassolas, G; Chazot, FB; Jaquet, P; Bachelot, I; Chanson, P; Rudelli, CC; Tauber, JP; Allannic, H; Bringer, J; Roudaut, N; Rohmer, V; Roger, P; Latapie, JL; Reville, P; Leutenegger, M
    GH deficiency in adults: an epidemiological approach
    EUROPEAN JOURNAL OF ENDOCRINOLOGY
    
    G. Sassolas et al., "GH deficiency in adults: an epidemiological approach", EUR J ENDOC, 141(6), 1999, pp. 595-600
17. Bringer, J; Lefebvre, P; Renard, E
    Nutrition and ovarian physiology
    M S-MEDECINE SCIENCES
    
    J. Bringer et al., "Nutrition and ovarian physiology", M S-MED SCI, 15(2), 1999, pp. 197-203
18. Renard, E; Fabre, J; Paris, F; Reynes, J; Bringer, J
    Syndrome of body fat redistribution in HIV-1-infected patients: relationships to cortisol and catecholamines
    CLINICAL ENDOCRINOLOGY
    
    E. Renard et al., "Syndrome of body fat redistribution in HIV-1-infected patients: relationships to cortisol and catecholamines", CLIN ENDOCR, 51(2), 1999, pp. 223-230
19. Renard, E; Souche, C; Jacques-Apostol, D; Lauton, D; Gibert-Boulet, F; Costalat, G; Bringer, J; Jaffiol, C
    Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin
    DIABETES CARE
    
    E. Renard et al., "Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin", DIABET CARE, 22(8), 1999, pp. 1371-1372
20. Studd, J; Pornel, B; Marton, I; Bringer, J; Varin, C; Tsouderos, Y; Christiansen, C
    Efficacy and acceptability of intranasal 17 beta-oestradiol for menopausalsymptoms: randomised dose-response study
    LANCET
    
    J. Studd et al., "Efficacy and acceptability of intranasal 17 beta-oestradiol for menopausalsymptoms: randomised dose-response study", LANCET, 353(9164), 1999, pp. 1574-1578
21. Jaffiol, C; Rouard, M; Macari, F; Lautier, C; El Mkadem, SA; Mechaly, I; Brun, JF; Renard, E; Cros, G; Bringer, J; Grigorescu, F
    Insulin resistance : from clinical diagnosis to molecular genetics. Implications in diabetes mellitus
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE
    
    C. Jaffiol et al., "Insulin resistance : from clinical diagnosis to molecular genetics. Implications in diabetes mellitus", B ACA N MED, 183(9), 1999, pp. 1761-1777
22. PEYREIGNE C; BOUIX D; MICALLEF JP; MERCIER J; BRINGER J; PREFAUT C; BRUN JF
    EXERCISE-INDUCED GROWTH-HORMONE SECRETION AND HEMORHEOLOGY DURING EXERCISE IN ELITE ATHLETES
    Clinical hemorheology and microcirculation
    
    C. Peyreigne et al., "EXERCISE-INDUCED GROWTH-HORMONE SECRETION AND HEMORHEOLOGY DURING EXERCISE IN ELITE ATHLETES", Clinical hemorheology and microcirculation, 19(2), 1998, pp. 169-176
23. KHALED S; BRUN JF; WAGNER A; MERCIER J; BRINGER J; PREFAUT C
    INCREASED BLOOD-VISCOSITY IN IRON-DEPLETED ELITE ATHLETES
    Clinical hemorheology and microcirculation
    
    S. Khaled et al., "INCREASED BLOOD-VISCOSITY IN IRON-DEPLETED ELITE ATHLETES", Clinical hemorheology and microcirculation, 18(4), 1998, pp. 309-318
24. GALTIERDEREURE F; BIRON C; VIES M; BOURGEOIS V; SCHVED JF; BRINGER J
    VASCULAR COMPLICATIONS OF DIABETES-MELLITUS - WHAT ROLE FOR PHOSPHOLIPID-BINDING ANTIBODIES
    Lupus
    
    F. Galtierdereure et al., "VASCULAR COMPLICATIONS OF DIABETES-MELLITUS - WHAT ROLE FOR PHOSPHOLIPID-BINDING ANTIBODIES", Lupus, 7(7), 1998, pp. 469-474
25. PUJOL P; OSMAN A; GRABAR S; DAURES JP; GALTIERDEREURE F; BOEGNER C; BALDET L; RAYE R; BRINGER J; JAFFIOL C
    TSH SUPPRESSION COMBINED WITH CARBIMAZOLE FOR GRAVES-DISEASE - EFFECTON REMISSION AND RELAPSE RATES
    Clinical endocrinology
    
    P. Pujol et al., "TSH SUPPRESSION COMBINED WITH CARBIMAZOLE FOR GRAVES-DISEASE - EFFECTON REMISSION AND RELAPSE RATES", Clinical endocrinology, 48(5), 1998, pp. 635-640
26. MELKI V; BELICAR P; RENARD E; JEANDIDIER N; LASSMANNVAGUE V; MEYER L; BOIVIN S; BLIN P; GUERCI B; AUGENDREFERRANTE B; HANAIREBROUTIN H; TAUBER JP; BRINGER J
    IMPROVEMENT OF HBA(1C) AND BLOOD-GLUCOSE STABILITY IN IDDM PATIENTS TREATED WITH LISPRO INSULIN ANALOG IN EXTERNAL PUMPS
    Diabetes care
    
    V. Melki et al., "IMPROVEMENT OF HBA(1C) AND BLOOD-GLUCOSE STABILITY IN IDDM PATIENTS TREATED WITH LISPRO INSULIN ANALOG IN EXTERNAL PUMPS", Diabetes care, 21(6), 1998, pp. 977-982
27. LAUTIER C; MACARI F; ELMKADEM SA; RENARD E; ROKIKI D; BRINGER J; JAFFIOL C; SMITH R; GRIGORESCU F
    PATHOGENIC ROLE OF MUTATIONS IN INSULIN AND IGF-1 RECEPTORS AND IRS-1GENES IN INSULIN-RESISTANCE
    Diabetologia
    
    C. Lautier et al., "PATHOGENIC ROLE OF MUTATIONS IN INSULIN AND IGF-1 RECEPTORS AND IRS-1GENES IN INSULIN-RESISTANCE", Diabetologia, 41, 1998, pp. 666-666
28. GRIGORESCU F; POUCHERET P; BOUIX O; LAUTIER C; RENARD E; MACARI F; BRINGER J; CROS G; WIENSPERGER N; SERRANO JJ
    METFORMIN POTENTIATES PHOSPHATIDYLINOSITOL-3' KINASE BY IRS-2 RECRUITMENT IN RAT HEPATIC TISSUE
    Diabetologia
    
    F. Grigorescu et al., "METFORMIN POTENTIATES PHOSPHATIDYLINOSITOL-3' KINASE BY IRS-2 RECRUITMENT IN RAT HEPATIC TISSUE", Diabetologia, 41, 1998, pp. 735-735
29. GRIGORESCU F; MACARI F; RENARD E; BRINGER J; JAFFIOL C
    HIGH-FREQUENCY OF GLY972-]ARG VARIANT OF IRS-1 GENE IN WOMEN WITH POLYCYSTIC-OVARY-SYNDROME AND INSULIN-RESISTANCE
    Diabetes
    
    F. Grigorescu et al., "HIGH-FREQUENCY OF GLY972-]ARG VARIANT OF IRS-1 GENE IN WOMEN WITH POLYCYSTIC-OVARY-SYNDROME AND INSULIN-RESISTANCE", Diabetes, 47, 1998, pp. 969-969
30. GALTIERDEREURE F; BRINGER J
    MATERNAL WEIGHT-GAIN AND PREGNANCY
    DIABETES & METABOLISM
    
    F. Galtierdereure e J. Bringer, "MATERNAL WEIGHT-GAIN AND PREGNANCY", DIABETES & METABOLISM, 23(6), 1997, pp. 549-553
31. BRUN JF; BRINGER J; RAYNAUD E; RENARD E; ORSETTI A
    INTERRELATION OF VISCERAL FAT AND MUSCLE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - PRACTICAL IMPLICATIONS
    DIABETES & METABOLISM
    
    J.F. Brun et al., "INTERRELATION OF VISCERAL FAT AND MUSCLE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - PRACTICAL IMPLICATIONS", DIABETES & METABOLISM, 23, 1997, pp. 16-34
32. BRINGER J; LEFEBVRE P
    HORMONAL REPLACEMENT THERAPY IN WOMEN WIT H METABOLIC DISORDERS
    Contraception fertilite sexualite
    
    J. Bringer e P. Lefebvre, "HORMONAL REPLACEMENT THERAPY IN WOMEN WIT H METABOLIC DISORDERS", Contraception fertilite sexualite, 25(10), 1997, pp. 757-760
33. BIRON C; GALTIERDEREURE F; VIES M; PICOT MC; BOURGEOIS V; BRINGER J; SCHVED JF
    ANTIPHOSPHOLIPID ANTIBODIES (APA) AND VASCULAR COMPLICATIONS IN DIABETES-MELLITUS
    Thrombosis and haemostasis
    
    C. Biron et al., "ANTIPHOSPHOLIPID ANTIBODIES (APA) AND VASCULAR COMPLICATIONS IN DIABETES-MELLITUS", Thrombosis and haemostasis, 1997, pp. 1377-1377
34. PUJOL P; OSMAN A; BRINGER J; JAFFIOL C
    UNTITLED
    Clinical endocrinology
    
    P. Pujol et al., "UNTITLED", Clinical endocrinology, 46(1), 1997, pp. 121-122
35. SCAVINI M; GALLI L; REICH S; EATON RP; CHARLES MA; DUNN FL; MICOSSI P; TORRI M; PETRELLA G; GALIMBERTI G; CRISTALLO M; VAI S; POZZA G; OLSEN C; TURNER D; NOLLEMAN C; LAVINTOMPKINS J; SELAM JL; HAARDT MJ; DORANGE C; JEANDIDIER N; ORTEGA F; BOIVIN S; NATHAN D; LARKIN M; MCKITRICK C; SCHWARZ S; FISHER J; KIPNES S; WALZ B; VAGUE P; REEVES ML; GOUDNER M; THOMSON GP; JAFFIOL C; RENARD E; LAUTON D; JACQUESAPOSTOL D; BRINGER J; TAUBER JP; HANAIREBROUTIN H; REESJONES R; ADOLFF S; BAYS HA; PFEIFER M; CLARKE D; IRSIGLER K; FEINBOCH C; HUTTER R; MENDEL H; DIGLAS J
    CATHETER SURVIVAL DURING LONG-TERM INSULIN THERAPY WITH AN IMPLANTED PROGRAMMABLE PUMP
    Diabetes care
    
    M. Scavini et al., "CATHETER SURVIVAL DURING LONG-TERM INSULIN THERAPY WITH AN IMPLANTED PROGRAMMABLE PUMP", Diabetes care, 20(4), 1997, pp. 610-613
36. HANAIRE H; BRINGER J; LASSMANNVAGUE V; JEANDIDIER N; MEYER L; BLIN P; TAUBER JP; AUGENDRE B
    IMPROVEMENT OF HBA1C WITHOUT INCREASING HYPOGLYCEMIA RISK IN DIABETIC-PATIENTS TREATED WITH INSULIN LISPRO IN EXTERNA PUMPS
    Diabetologia
    
    H. Hanaire et al., "IMPROVEMENT OF HBA1C WITHOUT INCREASING HYPOGLYCEMIA RISK IN DIABETIC-PATIENTS TREATED WITH INSULIN LISPRO IN EXTERNA PUMPS", Diabetologia, 40, 1997, pp. 31-31
37. GRIGORESCU F; ROUARD M; MACARI F; BOUIX O; BRUN JF; RENARD E; LEFEBVRE P; LAUTIER C; BRINGER J; JAFFIOL C
    ASSOCIATION OF IRS-1 ASP(972)-]GLY VARIANT WITH INSULIN-RECEPTOR MUTATIONS IN INSULIN-RESISTANT DIABETES
    Diabetologia
    
    F. Grigorescu et al., "ASSOCIATION OF IRS-1 ASP(972)-]GLY VARIANT WITH INSULIN-RECEPTOR MUTATIONS IN INSULIN-RESISTANT DIABETES", Diabetologia, 40, 1997, pp. 619-619
38. RENARD E; BACCARA MT; BOULOT P; LEFEBVRE P; BRINGER J; JAFFIOL C
    OUTCOMES OF IDDM PREGNANCIES - SIGNIFICANT BENEFITS ASSOCIATED WITH CONCEPTION PLANNING
    Diabetologia
    
    E. Renard et al., "OUTCOMES OF IDDM PREGNANCIES - SIGNIFICANT BENEFITS ASSOCIATED WITH CONCEPTION PLANNING", Diabetologia, 40, 1997, pp. 895-895
39. GALTIERDEREURE F; BIRON C; VIES M; BOURGEOIS V; SCHVED JF; BRINGER J
    VASCULAR COMPLICATIONS OF DIABETES-MELLITUS - ROLE OF ANTIPHOSPHOLIPID ANTIBODIES
    Diabetologia
    
    F. Galtierdereure et al., "VASCULAR COMPLICATIONS OF DIABETES-MELLITUS - ROLE OF ANTIPHOSPHOLIPID ANTIBODIES", Diabetologia, 40, 1997, pp. 1606-1606
40. MACARI F; ROUARD M; BOUIX O; BRUN JF; RENARD E; BRINGER J; OLIVER C; JAFFIOL C; GRIGORESCU F
    PATHOGENIC ROLE OF ASSOCIATED MUTATIONS OF IRS-1 AND INSULIN-RECEPTOR(IR) IN INSULIN-RESISTANCE
    Diabetes
    
    F. Macari et al., "PATHOGENIC ROLE OF ASSOCIATED MUTATIONS OF IRS-1 AND INSULIN-RECEPTOR(IR) IN INSULIN-RESISTANCE", Diabetes, 46, 1997, pp. 1346-1346
41. ROUARD M; MACARI F; BOUIX O; LAUTIER C; BRUN JF; LEFEBVRE P; RENARD E; BRINGER J; JAFFIOL C; GRIGORESCU F
    IDENTIFICATION OF 2 NOVEL INSULIN-RECEPTOR MUTATIONS, ASP59GLY AND LEU62PRO, IN TYPE-A SYNDROME OF EXTREME INSULIN-RESISTANCE
    Biochemical and biophysical research communications
    
    M. Rouard et al., "IDENTIFICATION OF 2 NOVEL INSULIN-RECEPTOR MUTATIONS, ASP59GLY AND LEU62PRO, IN TYPE-A SYNDROME OF EXTREME INSULIN-RESISTANCE", Biochemical and biophysical research communications, 234(3), 1997, pp. 764-768
42. GALTIERDEREURE F; BRINGER J; HEDON B
    PRONOSTIC VALUE OF HIGH FSH CONCENTRATION S
    Contraception fertilite sexualite
    
    F. Galtierdereure et al., "PRONOSTIC VALUE OF HIGH FSH CONCENTRATION S", Contraception fertilite sexualite, 24(9), 1996, pp. 635-638
43. GALTIERDEREURE F; DEBOUARD V; PICOT MC; VERGNES C; HUMEAU C; BRINGER J; HEDON B
    OVARIAN RESERVE TEST WITH THE GONADOTROPIN-RELEASING-HORMONE AGONIST BUSERELIN - CORRELATION WITH IN-VITRO FERTILIZATION OUTCOME
    Human reproduction
    
    F. Galtierdereure et al., "OVARIAN RESERVE TEST WITH THE GONADOTROPIN-RELEASING-HORMONE AGONIST BUSERELIN - CORRELATION WITH IN-VITRO FERTILIZATION OUTCOME", Human reproduction, 11(7), 1996, pp. 1393-1398
44. RENARD E; BOUTELEAU S; JACQUESAPOSTOL D; LAUTON D; GIBERTBOULET F; COSTALAT G; BRINGER J; JAFFIOL C
    INSULIN UNDERDELIVERY FROM IMPLANTED PUMPS USING PERITONEAL ROUTE - DETERMINANT ROLE OF INSULIN PUMP COMPATIBILITY
    Diabetes care
    
    E. Renard et al., "INSULIN UNDERDELIVERY FROM IMPLANTED PUMPS USING PERITONEAL ROUTE - DETERMINANT ROLE OF INSULIN PUMP COMPATIBILITY", Diabetes care, 19(8), 1996, pp. 812-817
45. PUJOL P; DAURES JP; NSAKALA N; BALDET L; BRINGER J; JAFFIOL C
    DEGREE OF THYROTROPIN SUPPRESSION AS A PROGNOSTIC DETERMINANT IN DIFFERENTIATED THYROID-CANCER
    The Journal of clinical endocrinology and metabolism
    
    P. Pujol et al., "DEGREE OF THYROTROPIN SUPPRESSION AS A PROGNOSTIC DETERMINANT IN DIFFERENTIATED THYROID-CANCER", The Journal of clinical endocrinology and metabolism, 81(12), 1996, pp. 4318-4323
46. RENARD E; BOUTELEAU S; BRINGER J; JAFFIOL C
    BENEFICIAL METABOLIC EFFECTS OF IMPLANTABLE INSULIN PUMPS ARE COUNTERBALANCED BY TECHNICAL INCIDENTS RELATED TO INSULIN-PUMP INCOMPATIBILITY
    Diabetes
    
    E. Renard et al., "BENEFICIAL METABOLIC EFFECTS OF IMPLANTABLE INSULIN PUMPS ARE COUNTERBALANCED BY TECHNICAL INCIDENTS RELATED TO INSULIN-PUMP INCOMPATIBILITY", Diabetes, 45, 1996, pp. 516-516
47. BACCARA MT; RENARD E; BOULOT P; BRINGER J; JAFFIOL C
    PRECONCEPTIONAL INTENSIVE INSULIN REGIMEN AND PREGNANCY PLANNING BOTHINDEPENDENTLY CONTRIBUTE TO IMPROVE OUTCOME OF IDDM PREGNANCIES
    Diabetes
    
    M.T. Baccara et al., "PRECONCEPTIONAL INTENSIVE INSULIN REGIMEN AND PREGNANCY PLANNING BOTHINDEPENDENTLY CONTRIBUTE TO IMPROVE OUTCOME OF IDDM PREGNANCIES", Diabetes, 45, 1996, pp. 1260-1260
48. LEFEBVRE P; BRINGER J
    CONTRACEPTION AND CORONARY-ARTERY DISEASE
    Archives des maladies du coeur et des vaisseaux
    
    P. Lefebvre e J. Bringer, "CONTRACEPTION AND CORONARY-ARTERY DISEASE", Archives des maladies du coeur et des vaisseaux, 89, 1996, pp. 33-37
49. BRINGER J; RENARD E; LEFEBVRE P
    POSTMENOPAUSAL HORMONE REPLACEMENT THERAP Y AND CORONARY RISK
    Archives des maladies du coeur et des vaisseaux
    
    J. Bringer et al., "POSTMENOPAUSAL HORMONE REPLACEMENT THERAP Y AND CORONARY RISK", Archives des maladies du coeur et des vaisseaux, 89, 1996, pp. 63-69
50. BRINGER J
    MEDICAL-TREATMENT OF HYPOPHYSEAL DISORDER S
    Annales d'Endocrinologie
    
    J. Bringer, "MEDICAL-TREATMENT OF HYPOPHYSEAL DISORDER S", Annales d'Endocrinologie, 57(6), 1996, pp. 492-493
51. JAFFIOL C; JACQUESAPOSTOL D; RENARD E; MILLET P; COMPEYRE S; LAUTON D; PICOT MC; BRINGER J
    EVOLUTION OF BLOOD-GLUCOSE CONTROL AND RE TINOPATHY DURING LONG-TERM TREATMENT OF INSULIN-DEPENDENT DIABETES-MELLITUS USING INTRAPERITONEALINSULIN INFUSION
    Bulletin de l'Academie nationale de medecine
    
    C. Jaffiol et al., "EVOLUTION OF BLOOD-GLUCOSE CONTROL AND RE TINOPATHY DURING LONG-TERM TREATMENT OF INSULIN-DEPENDENT DIABETES-MELLITUS USING INTRAPERITONEALINSULIN INFUSION", Bulletin de l'Academie nationale de medecine, 180(1), 1996, pp. 177-194
52. GALTIERDEREURE F; BRINGER J
    FSH DOSAGE IN TREATMENT OF INFERTILITY
    Contraception fertilite sexualite
    
    F. Galtierdereure e J. Bringer, "FSH DOSAGE IN TREATMENT OF INFERTILITY", Contraception fertilite sexualite, 23(4), 1995, pp. 215-218
53. PUJOL P; BRINGER J; FAUROUS P; JAFFIOL C
    METASTATIC PHEOCHROMOCYTOMA WITH A LONG-TERM RESPONSE AFTER I-131 METAIODOBENZYLGUANIDINE THERAPY
    European journal of nuclear medicine
    
    P. Pujol et al., "METASTATIC PHEOCHROMOCYTOMA WITH A LONG-TERM RESPONSE AFTER I-131 METAIODOBENZYLGUANIDINE THERAPY", European journal of nuclear medicine, 22(4), 1995, pp. 382-384
54. GALTIERDEREURE F; MONTPEYROUX F; BOULOT P; BRINGER J; JAFFIOL C
    WEIGHT EXCESS BEFORE PREGNANCY - COMPLICATIONS AND COST
    International journal of obesity
    
    F. Galtierdereure et al., "WEIGHT EXCESS BEFORE PREGNANCY - COMPLICATIONS AND COST", International journal of obesity, 19(7), 1995, pp. 443-448
55. RENARD E; BALDET P; PICOT MC; JACQUESAPOSTOL D; LAUTON D; COSTALAT G; BRINGER J; JAFFIOL C
    CATHETER COMPLICATIONS ASSOCIATED WITH IMPLANTABLE SYSTEMS FOR PERITONEAL INSULIN DELIVERY - AN ANALYSIS OF FREQUENCY, PREDISPOSING FACTORS, AND OBSTRUCTING MATERIALS
    Diabetes care
    
    E. Renard et al., "CATHETER COMPLICATIONS ASSOCIATED WITH IMPLANTABLE SYSTEMS FOR PERITONEAL INSULIN DELIVERY - AN ANALYSIS OF FREQUENCY, PREDISPOSING FACTORS, AND OBSTRUCTING MATERIALS", Diabetes care, 18(3), 1995, pp. 300-306
56. HANAIREBROUTIN H; BROUSSOLLE C; JEANDIDIER N; RENARD E; GUERCI B; HAARDT MJ; LASSMANNVAGUE V; PINGET M; TAUBER JP; BRINGER J; VAGUE P; RACCAH D; DROUIN P; ZIEGLER O; SELAM JL; SLAMA G; GILLY F
    FEASIBILITY OF INTRAPERITONEAL INSULIN THERAPY WITH PROGRAMMABLE IMPLANTABLE PUMPS IN IDDM - A MULTICENTER STUDY
    Diabetes care
    
    H. Hanairebroutin et al., "FEASIBILITY OF INTRAPERITONEAL INSULIN THERAPY WITH PROGRAMMABLE IMPLANTABLE PUMPS IN IDDM - A MULTICENTER STUDY", Diabetes care, 18(3), 1995, pp. 388-392
57. RENARD E; TAOUREL P; QUENET F; DOMERGUE J; BRUEL JM; BRINGER J
    CECUM EROSION - UNUSUAL BUT SERIOUS COMPLICATION OF AN IMPLANTED CATHETER FOR PERITONEAL INSULIN DELIVERY
    Diabetes care
    
    E. Renard et al., "CECUM EROSION - UNUSUAL BUT SERIOUS COMPLICATION OF AN IMPLANTED CATHETER FOR PERITONEAL INSULIN DELIVERY", Diabetes care, 18(3), 1995, pp. 408-409
58. RICHARD JL; BRINGER J; PARERRICHARD C; RODIER M; DAURES JP; JACOB C; CLOUET S; COMTEBARDONNET M; VANNEREAU D
    EFFECT OF TOPICAL BASIC FIBROBLAST GROWTH-FACTOR ON THE HEALING OF CHRONIC DIABETIC NEUROPATHIC ULCER OF THE FOOT - A PILOT, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Diabetes care
    
    J.L. Richard et al., "EFFECT OF TOPICAL BASIC FIBROBLAST GROWTH-FACTOR ON THE HEALING OF CHRONIC DIABETIC NEUROPATHIC ULCER OF THE FOOT - A PILOT, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY", Diabetes care, 18(1), 1995, pp. 64-69
59. ROUARD M; RENARD E; LEFEBVRE P; BRINGER J; MACARI F; GRIGORESCU F; JAFFIOL C
    DEFECT IN PHOSPHATIDYLINOSITOL (PTDINS)-3' KINASE ACTIVATION IN TYPE-A SYNDROME WITH ASP-]GLY(59) INSULIN-RECEPTOR GENE MUTATION
    Diabetologia
    
    M. Rouard et al., "DEFECT IN PHOSPHATIDYLINOSITOL (PTDINS)-3' KINASE ACTIVATION IN TYPE-A SYNDROME WITH ASP-]GLY(59) INSULIN-RECEPTOR GENE MUTATION", Diabetologia, 38, 1995, pp. 137-137
60. RENARD E; GRIGORESCU F; PERNEY P; BRUN JF; DOMERGUE J; BRINGER J
    INSULIN-RESISTANCE IN LIPOATROPHIC DIABETES REVISITED FROM A UNIQUE EXPERIENCE OF LIVER-TRANSPLANTATION
    Diabetologia
    
    E. Renard et al., "INSULIN-RESISTANCE IN LIPOATROPHIC DIABETES REVISITED FROM A UNIQUE EXPERIENCE OF LIVER-TRANSPLANTATION", Diabetologia, 38, 1995, pp. 140-140
61. JAFFIOL C; DAURES JP; NSAKALA N; GUERENOVA J; BALDET L; PUJOL P; VANNEREAU D; BRINGER J
    LONG-TERM FOLLOW-UP OF MEDICAL THERAPY OF THYROID-CANCER
    Annales d'Endocrinologie
    
    C. Jaffiol et al., "LONG-TERM FOLLOW-UP OF MEDICAL THERAPY OF THYROID-CANCER", Annales d'Endocrinologie, 56(2), 1995, pp. 119-126
62. BRINGER J; RENARD E; DEREURE FG; JAFFIOL C
    PERSPECTIVES IN THE TREATMENT OF TYPE-2 DIABETES - PLACE OF INSULIN THERAPY
    Diabete et metabolisme
    
    J. Bringer et al., "PERSPECTIVES IN THE TREATMENT OF TYPE-2 DIABETES - PLACE OF INSULIN THERAPY", Diabete et metabolisme, 20(2BIS), 1994, pp. 211-218
63. RENARD E; MESTRE C; BRINGER J; COSTALAT G; JACQUESAPOSTOL D; JAFFIOL C; LAUTON D
    COMPLICATIONS OF THE PUMP POCKET MAY REPRESENT A SIGNIFICANT CAUSE OFINCIDENTS WITH IMPLANTED SYSTEMS FOR INTRAPERITONEAL INSULIN DELIVERY
    Diabetes care
    
    E. Renard et al., "COMPLICATIONS OF THE PUMP POCKET MAY REPRESENT A SIGNIFICANT CAUSE OFINCIDENTS WITH IMPLANTED SYSTEMS FOR INTRAPERITONEAL INSULIN DELIVERY", Diabetes care, 17(9), 1994, pp. 1064-1066
64. RENARD E; BRINGER J
    EFFICACY OF CONTINUOUS PERITONEAL INSULIN INFUSION FROM IMPLANTED SYSTEMS (CPII-IS) IN IDDM - RESULTS OF A LARGE-SCALE OBSERVATIONAL STUDY
    Diabetes
    
    E. Renard e J. Bringer, "EFFICACY OF CONTINUOUS PERITONEAL INSULIN INFUSION FROM IMPLANTED SYSTEMS (CPII-IS) IN IDDM - RESULTS OF A LARGE-SCALE OBSERVATIONAL STUDY", Diabetes, 43, 1994, pp. 10000220-10000220
65. BRINGER J; LHORET RR; HEDON B; LEFEBVRE P
    GROWTH-HORMONE (HGH) USING OVULATION INDU CTION IN THE WOMAN
    Contraception fertilite sexualite
    
    J. Bringer et al., "GROWTH-HORMONE (HGH) USING OVULATION INDU CTION IN THE WOMAN", Contraception fertilite sexualite, 21(9), 1993, pp. 678-682
66. LOBACCARO JM; LUMBROSO S; BELON C; GALTIERDEREURE F; BRINGER J; LESIMPLE T; HERON JF; PUJOL H; SULTAN C
    MALE BREAST-CANCER AND THE ANDROGEN RECEPTOR GENE
    Nature genetics
    
    J.M. Lobaccaro et al., "MALE BREAST-CANCER AND THE ANDROGEN RECEPTOR GENE", Nature genetics, 5(2), 1993, pp. 109-110
67. LOBACCARO JM; LUMBROSO S; BELON C; GALTIERDEREURE F; BRINGER J; LESIMPLE T; NAMER M; CUTULI BF; PUJOL H; SULTAN C
    ANDROGEN RECEPTOR GENE MUTATION IN MALE BREAST-CANCER
    Human molecular genetics
    
    J.M. Lobaccaro et al., "ANDROGEN RECEPTOR GENE MUTATION IN MALE BREAST-CANCER", Human molecular genetics, 2(11), 1993, pp. 1799-1802
68. RENARD E; LAUTON D; BONIFACJ C; COSTALAT G; JACQUES D; BRINGER J; JAFFIOL C
    EXPERIENCE WITH INTRAPERITONEAL INSULIN INFUSION FROM IMPLANTABLE PROGRAMMABLE SYSTEMS IN TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS PREVIOUSLY TREATED BY EXTERNAL PUMPS
    Diabete et metabolisme
    
    E. Renard et al., "EXPERIENCE WITH INTRAPERITONEAL INSULIN INFUSION FROM IMPLANTABLE PROGRAMMABLE SYSTEMS IN TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS PREVIOUSLY TREATED BY EXTERNAL PUMPS", Diabete et metabolisme, 19(4), 1993, pp. 364-371
69. RACCAH D; RENARD E; ZIEGLER O; SELAM JL; BROUSSOLE C; JEANDIDIER N; BROUTIN H; VAGUE V; BRINGER J; GUERCI B; HAARDT MJ; GILLY F; PINGET M; TAUBER JP; VAGUE P
    MULTICENTER EVALUATION OF METABOLIC RESUL TS OF TREATMENTS USING IMPLANTED INSULIN PUMPS
    La Revue de medecine interne
    
    D. Raccah et al., "MULTICENTER EVALUATION OF METABOLIC RESUL TS OF TREATMENTS USING IMPLANTED INSULIN PUMPS", La Revue de medecine interne, 14(6), 1993, pp. 455-455
70. BONNETBLANC JM; BEYLOT C; BELAICH S; VIDAL E; WECHSLER B; TOBELEM G; BLANC B; BRINGER J; MARES M
    CONTRACEPTION AND BEHCETS-DISEASE
    Annales de dermatologie et de venereologie
    
    J.M. Bonnetblanc et al., "CONTRACEPTION AND BEHCETS-DISEASE", Annales de dermatologie et de venereologie, 120(5), 1993, pp. 417-418
71. LUMBROSO S; LOBACCARO JM; BELON C; AMRAM S; RODIER M; BRINGER J; SULTAN C
    SUBSTITUTION OF ARGININE-840 BY HISTIDINE IN THE ANDROGEN RECEPTOR OFA FAMILY WITH REIFENSTEIN SYNDROME
    Comptes rendus des seances de la Societe de biologie et de ses filiales
    
    S. Lumbroso et al., "SUBSTITUTION OF ARGININE-840 BY HISTIDINE IN THE ANDROGEN RECEPTOR OFA FAMILY WITH REIFENSTEIN SYNDROME", Comptes rendus des seances de la Societe de biologie et de ses filiales, 187(4), 1993, pp. 508-515
72. JEANDIDIER N; HANAIREBROUTIN H; LASSMANNVAGUE V; RENARD E; GUERCI B; HAARDT MJ; BROSSOLE C; BOIVIN S; TAUBER TP; VAGUE P; BRINGER J; DROUIN P; SELAM JL; GILLY F
    SAFETY AND EFFICACY OF LONG-TERM INTRAPERITONEAL INSULIN INFUSION BY MEANS OF IMPLANTABLE-PUMPS - THE EVADIAC SURVEY
    Diabetologia
    
    N. Jeandidier et al., "SAFETY AND EFFICACY OF LONG-TERM INTRAPERITONEAL INSULIN INFUSION BY MEANS OF IMPLANTABLE-PUMPS - THE EVADIAC SURVEY", Diabetologia, 36, 1993, pp. 10000037-10000037
73. GUERCI B; HAARDT MJ; BROUSSOLLE C; JEANDIDIER N; HANAIREBROUTIN H; RACCAH D; RENARD E; DROUIN P; SELAM JL; GILLY F; PINGET M; TAUBER JP; LASSMANNVAGUE V; BRINGER J; VAGUE P
    LONG-TERM INTRAPERITONEAL INSULIN INFUSION USING IMPLANTABLE PUMPS - THE FRENCH MULTICENTRIC TRIAL
    Diabetes
    
    B. Guerci et al., "LONG-TERM INTRAPERITONEAL INSULIN INFUSION USING IMPLANTABLE PUMPS - THE FRENCH MULTICENTRIC TRIAL", Diabetes, 42, 1993, pp. 55-55